Micro Meditex Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 03-01-2025
- Paid Up Capital ₹ 3.00 M
as on 03-01-2025
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 48.83 Cr
as on 03-01-2025
- Revenue 12.35%
(FY 2023)
- Profit 60.19%
(FY 2023)
- Ebitda -37.85%
(FY 2023)
- Net Worth 8.59%
(FY 2023)
- Total Assets -0.21%
(FY 2023)
About Micro Meditex
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company has closed loans amounting to ₹48.83 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Narayanan Aickattu, Jaya Narayanan, Vasanthy, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24236KL2003PTC016445
- Company No.
016445
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2003
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Micro Meditex?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aickattu Swathy  | Managing Director | 16-May-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sahil Nair | Additional Director | 19-Aug-2019 | Current |
| Narayanan Aickattu | Director | 16-May-2023 | Current |
| Jaya Narayanan | Director | 16-May-2023 | Current |
| Vasanthy | Director | 28-Jan-2019 | Current |
| Kumaran Pradosh | Director | 28-Jan-2019 | Current |
Financial Performance of Micro Meditex.
Micro Meditex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.35% increase. The company also saw a substantial improvement in profitability, with a 60.19% increase in profit. The company's net worth moved up by a moderate rise of 8.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Micro Meditex?
In 2023, Micro Meditex had a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Aug 2007 | ₹5.80 M | Satisfied |
Union Bank Of India Creation Date: 10 Nov 2004 | ₹2.50 M | Satisfied |
Union Bank Of India Creation Date: 27 Apr 2004 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Micro Meditex?
Micro Meditex has a workforce of 8 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Micro Meditex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Micro Meditex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
